4.00
0.05 (1.27%)
Penutupan Terdahulu | 3.95 |
Buka | 4.00 |
Jumlah Dagangan | 2,300 |
Purata Dagangan (3B) | 10,437 |
Modal Pasaran | 593,256,000 |
Harga / Pendapatan (P/E TTM) | 14.81 |
Harga / Pendapatan (P/E Ke hadapan) | 12.21 |
Harga / Jualan (P/S) | 2.61 |
Harga / Buku (P/B) | 2.38 |
Julat 52 Minggu | |
Hasil Dividen (DY TTM) | 6.38% |
Margin Keuntungan | 16.98% |
Margin Operasi (TTM) | 25.18% |
EPS Cair (TTM) | 0.270 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -5.40% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -5.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.22% |
Nisbah Semasa (MRQ) | 2.33 |
Aliran Tunai Operasi (OCF TTM) | 54.47 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.12 M |
Pulangan Atas Aset (ROA TTM) | 9.48% |
Pulangan Atas Ekuiti (ROE TTM) | 15.02% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (MY) | Bercampur | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
Stok | KOTRA | Bercampur | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | NA |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 4.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 0.5 |
Purata | 2.50 |
Kotra Industries Bhd is an investment holding company. Along with its subsidiaries, the company is engaged in research and development, manufacturing, and trading of pharmaceutical and healthcare products. Its product range includes nutraceutical and pharmaceutical products. It offers tablets, capsules, creams, and ointments under the brand names, Appeton, Axcel, AxPain, Creobic, Arite, and Vaxcel. The geographical segments of the company are based on the country in which its customers are located and include Malaysia and Overseas. It generates maximum revenue from Malaysia. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 82.55% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
02 Apr 2025 | TheEdge | Duopharma Biotech back on growth path as focus on revenue pays off |
28 Feb 2025 | Pengumuman | Change in Nomination Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Pengumuman | Change in Audit Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Pengumuman | Change in Audit Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Pengumuman | Change in Remuneration Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Pengumuman | Change in Nomination Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Pengumuman | Change in Remuneration Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Pengumuman | Change in Boardroom - MR PIONG CHEE KIEN |
19 Feb 2025 | Pengumuman | Quarterly rpt on consolidated results for the financial period ended 31/12/2024 |
Hasil Dividen (DY TTM) | 6.38% |
Purata Hasil Dividen 5T | 4.71% |
Nisbah Pembayaran | 140.85% |
Jangkaan Pembayaran Dividen Seterusnya | Oct 2025 |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
16 Dec 2024 | 27 Nov 2024 | 26 Dec 2024 | 0.125 Tunai |
30 Sep 2024 | 19 Aug 2024 | 10 Oct 2024 | 0.13 Tunai |
11 Mar 2024 | 21 Feb 2024 | 21 Mar 2024 | 0.125 Tunai |
02 Oct 2023 | 23 Aug 2023 | 12 Oct 2023 | 0.155 Tunai |
13 Mar 2023 | 24 Feb 2023 | 23 Mar 2023 | 0.1 Tunai |
30 Nov 2022 | 06 Oct 2022 | 08 Dec 2022 | 0.16 Tunai |
14 Mar 2022 | 24 Feb 2022 | 24 Mar 2022 | 0.095 Tunai |
29 Nov 2021 | 06 Oct 2021 | 09 Dec 2021 | 0.07 Tunai |
08 Mar 2021 | 19 Feb 2021 | 18 Mar 2021 | 0.02 Tunai |
27 Nov 2020 | 02 Oct 2020 | 10 Dec 2020 | 0.045 Tunai |
24 Feb 2020 | 05 Feb 2020 | 06 Mar 2020 | 0.045 Tunai |
02 Dec 2019 | 10 Oct 2019 | 13 Dec 2019 | 0.044 Tunai |
Papar semua |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2024 | 0.380 | 3 | 8.56 |
2023 | 0.255 | 2 | 5.28 |
2022 | 0.255 | 2 | 3.86 |
2021 | 0.090 | 2 | 2.85 |
2020 | 0.090 | 2 | 3.01 |
2019 | 0.044 | 1 | 2.34 |
Papar semua |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |